Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

Clinical trial NCT04906096 · RECRUITING

Trial details

NCT number: NCT04906096
Sponsor: Lakshmi Nayak, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma Non-Hodgkin Lymphoma of Extranodal Site

Start date: 2021-06-01
Primary completion: 2026-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.